Clinical Trials on HER2 Positive Breast Cancers in Japan
Total 217 results
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastJapan
-
AstraZenecaCompleted
-
Anwar Ali Ahmad AlameerCompletedEffect of Health Education Regarding Screening Tools of Breast CancerSaudi Arabia
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate Cancer, Advanced Breast CancerJapan
-
Eisai Co., Ltd.Completed
-
Comprehensive Support Project for Oncology ResearchNovartis PharmaceuticalsCompleted
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Translational Research Center for Medical Innovation...Completed
-
Eisai Co., Ltd.Completed
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerJapan
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Kyowa Kirin Co., Ltd.Completed
-
SanofiActive, not recruiting
-
Translational Research Center for Medical Innovation...Kyoto Breast Cancer Research NetworkCompleted
-
R-PharmCompleted
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerJapan
-
Tohoku UniversityCompleted
-
M.D. Anderson Cancer CenterTerminatedBreast CancerUnited States, Japan
-
Bristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedBreast Cancer | Neoplasm MetastasisJapan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
HekabioCompletedBreast Cancer | Head and Neck CancerJapan
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Novartis PharmaceuticalsActive, not recruiting
-
PfizerCompleted
-
R-PharmCompleted
-
Daiichi Sankyo Co., Ltd.Daiichi Sankyo, Inc.CompletedMetastatic Breast CancerUnited States, Japan
-
Novartis PharmaceuticalsCompletedEsophageal Cancer | Triple Negative Breast Cancer | Head & Neck CancerFrance, Singapore, Italy, Japan, United States, Spain
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerJapan
-
Ludwig Institute for Cancer ResearchMie UniversityCompletedStomach Cancer | Breast Cancer | Esophageal Cancer | Ovarian Cancer | Lung CancerJapan
-
AstraZenecaCompleted
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
TakedaCompletedPremenopausal Breast CancerJapan
-
PfizerCompleted
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingBreast CancerUnited States, Japan, Puerto Rico
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
PfizerActive, not recruitingBreast CancerJapan, Korea, Republic of, Taiwan
-
Federal University of São PauloEmory University; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University... and other collaboratorsActive, not recruitingBreast CancerBrazil, Canada, Italy, Japan
-
AstraZenecaCompletedAdvanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast CancerCanada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
Eli Lilly and CompanyTerminatedHepatocellular Carcinoma | Solid Tumor | Gastric Adenocarcinoma | Leiomyosarcoma | Head and Neck Squamous Cell Carcinoma | Cervical Carcinoma | Triple-negative Breast Cancer | Undifferentiated Pleomorphic Sarcoma | High Grade Serous Ovarian CarcinomaUnited States, Japan
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
PfizerJapan Breast Cancer Research Group (JBCRG)Completed